DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Diphenidine
Diphenidine
FSI-D-16-00226R1 Title
Acute Toxicity Associated with the Recreational Use of the Novel Dissociative Psychoactive Substance Methoxphenidine
Diphenidine
CREW NPS Booklet
Guidance on the Clinical Management of Acute and Chronic Harms of Club Drugs and Novel Psychoactive Substances NEPTUNE
Newer Unregulated Drugs Look-Up Table
Appendix-2Final.Pdf 663.7 KB
Schifano, F., Napoletano, F., Chiappini, S., Orsolini, L., Guirguis, A., Corkery, J
Laws and Rules Related to the Practice of Pharmacy in South Dakota
Selected Articles on the Analysis of Drugs of Abuse in Seized Materials (January-June 2017) Differentiation of Ring-Substituted
Synthesis, Characterisation and Development of Novel, Validated Methods for the Detection and Quantification of Diphenidine- Derived New Psychoactive Substances
An Approach to the New Psychoactive Drugs Phenomenon
When Good Times Go Bad: Managing 'Legal High' Complications in The
A New Psychoactive Agent with Ketamine-Like NMDA Receptor Antagonist Properties
Paper-Fluidic Presumptive Testing of the New Psychoactive Substance, Diphenidine P
Application and Assessment of Deep Learning for the Generation Of
LJMU Research Online
[Docket No. FDA-2021-N-0165] International
Top View
WO 2015/171770 Al 12 November 2015 (12.11.2015) P O P C T
From PCP to MXE: a Comprehensive Review of the Non-Medical Use of Dissociative Drugs Hamilton Morrisa and Jason Wallachb*
New Psychoactive Substances: Towards a Conceptual Delimitation
Newer Unregulated Drugs
Molecular Mechanisms of Action of Novel Psychoactive Substances (NPS)
Effects of Dissociative Anaesthetics on Driving
Substance Abuse in the Workplaces of Our Bodies and Mind
WO 2014/018563 A2 30 January 2014 (30.01.2014)
43Rd Expert Committee on Drug Dependence
The Lifespan of New Psychoactive Substances (NPS) and Vendors Selling NPS
U-47700 and Its Analogs: Non-Fentanyl Synthetic Opioids Impacting the Recreational Drug Market
New/Emerging Psychoactive Substances and Associated Psychopathological Consequences
Ephenidine: a New Psychoactive Agent with Ketamine-Like NMDA Receptor Antagonist Properties
Ephenidine: a New Psychoactive Agent with Ketamine-Like NMDA Receptor Antagonist Properties
Guidance on the Clinical Management of Acute and Chronic Harms of Club Drugs and Novel Psychoactive Substances NEPTUNE
Prescribing and Over-The-Counter Drugs
2-MEO-Diphenidine 2-MXP
4164-01-P Department of Health and Human Services
New Psychoactive Substances – New Analytical Challenges and Approaches
Evaluating and Expanding Knowledge and Awareness of Health
Phase 1B Pharmaco-MRS Pilot Study of Clavulanic Acid After Repeated Administration
Combined NMDA Inhibitor Use in a Patient with Multisubstance-Induced Psychotic Disorder] November 18, 2017
The 2016 “Research on Drug Evidence” Report [From the 18Th ICPO / INTERPOL Forensic Science Symposium]
Summary Assessment and Recommendations of the 43Rd ECDD, 12-16 October 2020
Research Chemical’ Diphenidine, Its Pyrrolidine Analogue, and Their 2,2-Diphenylethyl Isomers
Accepted Author Manuscript
Drugs Wheel Leaflet (Pdf)
Methoxphenidine (1-(1-(2-Methoxyphenyl)-2-Phenylethyl) Piperidine; 2-Meo-Diphenidine): Preliminary Data on Chemical, Pharmacological and Clinical Effects L
Federal Register/Vol. 86, No. 31/Thursday, February 18, 2021